BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2045312)

  • 1. HDR in gynecological applications: dose and volume considerations.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1379-80; author reply 1381. PubMed ID: 2045312
    [No Abstract]   [Full Text] [Related]  

  • 2. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.
    Ling CC; Sahoo N; Leibel S; Anderson LL
    Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HDR or LDR in gynecological brachytherapy?].
    Prager W
    Strahlenther Onkol; 1994 Jun; 170(6):368. PubMed ID: 8023249
    [No Abstract]   [Full Text] [Related]  

  • 4. HDR versus LDR gynaecological brachytherapy revisited.
    Jones B; Tan LT; Kingston R
    Radiother Oncol; 1994 Feb; 30(2):186. PubMed ID: 8184123
    [No Abstract]   [Full Text] [Related]  

  • 5. Accuracy of dose delivery in gynecological brachytherapy.
    Tenhunen M; Lahtinen T; Forss M; Kulmala J; Pitkänen M; Pitkänen U
    Acta Oncol; 1997; 36(5):527-9. PubMed ID: 9292750
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences with interstitial HDR afterloading therapy in genital and breast cancer.
    Jacobs H
    Sonderb Strahlenther Onkol; 1988; 82():258-62. PubMed ID: 3134722
    [No Abstract]   [Full Text] [Related]  

  • 7. HDR brachytherapy with improved accuracy using anatomically adapted treatment planning.
    Ragnhult I; Himmelmann A
    Sonderb Strahlenther Onkol; 1988; 82():90-3. PubMed ID: 3134733
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrospective analysis of multi-institutional, patient-specific treatment planning results of high-dose-rate intracavitary brachytherapy for gynecological cancer using V
    Watanabe T; Miyashita H; Notake R; Todoroki K; Nakajima G; Washizu K; Utsumi N; Hatanaka S; Hariu M; Yamano T; Nishimura K; Shimbo M; Takahashi T
    Australas Phys Eng Sci Med; 2018 Dec; 41(4):1069-1074. PubMed ID: 30361917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "Analysis of factors affecting the therapeutic gain in high dose rate gynecological implants relative to low dose rate implants" [Med. Phys. 23, 419-425 (1996)].
    Dale RG
    Med Phys; 1996 Sep; 23(9):1575, 1577. PubMed ID: 8892255
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of three brachytherapy gynecological intercavitary treatment planning systems.
    Concannon PJ; Mermis N; Nguyen L; Palmer MB
    Med Dosim; 2004; 29(2):115-7. PubMed ID: 15191758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging for gynecological HDR: tools and tricks.
    Herron BS; Chin DT; Pollock JR
    Med Dosim; 2008; 33(4):310-4. PubMed ID: 18973860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method of preparing custom molds for intracavitary treatment of gynecological cancer.
    Peracchia G; Salti C
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):141-3. PubMed ID: 7061250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo dosimetry of high dose rate gynecologic interstitial brachytherapy.
    Desbiens M; D'Amours M; Afsharpour H; Verhaegen F; Lavallée MC; Thibault I; Vigneault É; Beaulieu L
    Radiother Oncol; 2013 Dec; 109(3):425-9. PubMed ID: 24135700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
    Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
    Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
    D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
    Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
    Davidson SE; Hendry JH; West CM
    Brachytherapy; 2009; 8(3):269-72. PubMed ID: 19643373
    [No Abstract]   [Full Text] [Related]  

  • 17. [The radiobiology of gynecologic HDR and LDR afterloading technics].
    Bauer M; Schulz-Wendtland R
    Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gynecologic intracavity brachytherapy of a high-dose intensity. A review of the literature].
    Bistolfi F; Papadia S; Scielzo G; Siragusa A; Leonardi S; Tomassini E; Grillo Ruggieri F; Guglielmi M; Brizzi C; Parietti E
    Radiol Med; 1988 Oct; 76(4):347-55. PubMed ID: 3055080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of temporal dose distribution in prolonged and fractionated brachytherapy of gynecologic tumors. Mathematically formulated models and clinical experiences in fractionated short-time-afterloading with high dose rates].
    Glaser FH; Grimm D; Heider KM
    Radiobiol Radiother (Berl); 1984; 25(2):231-40. PubMed ID: 6739765
    [No Abstract]   [Full Text] [Related]  

  • 20. Gynecologic endocavitary radiotherapy: method of intervention and dosimetric calculation.
    Schenone A; Scarpati D; Caldana PL; Taccini G; Ledda S; Bentivoglio G; Pilot A; Zucchi E; Ragni N
    Eur J Gynaecol Oncol; 1982; 3(2):74-80. PubMed ID: 6891923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.